Roger Gunn is Executive Vice President, Quantitative Data Science for Invicro, and Professor of Molecular Neuroimaging in the Division of Brain Sciences at Imperial College London.
He is currently working on an experimental medicine study for Dementias Platform UK examining 'glial' cells and their role in Alzheimer's disease.
He is also part of the Dementias Platform UK imaging network, and DPUK's Company Partner Forum.
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease
Ivan Koychev et al, (2019), BMJ, 9
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Koychev, Ivan et al, (2018), Journal of Alzheimer's Disease, 60, 283 - 293
EVALUATION OF NOVEL ASTROCYTE MARKER [11C]BU99008 PET IN ALZHEIMER’S DISEASE: A DEMENTIA PLATFORM U.K. EXPERIMENTAL MEDICINE STUDY
V. Calsolaro et al, (2018), Alzh&Dementia july 18 v14, issue7 p1640, 14, 842 - 843
RELATIONSHIP BETWEEN ASTROCYTE ACTIVATION USING [11C]BU99008 PET, GLUCOSE METABOLISM AND AMYLOID IN ALZHEIMER’S DISEASE: A DEMENTIA PLATFORM UK EXPERIMENTAL MEDICINE STUDY
Zhen Fan et al, (2018), Alzheimer's & Dementia, 14